Catalog No. (SRN958K) • US $4,850 • January 2024
Greystone Research Associates is pleased to announce the publication of a new market assessment. Using formulation technologies designed to modulate the effect of therapeutic substances, drug developers are creating formulations that exhibit extended release profiles. These chemistries include polymers such as polyethylene glycol-complexed (PEGylated), which are used to product encapsulated and coated versions of new APIs. The goal is to address the requirement for patient-dependent, and therefore compliance-sensitive, drug treatment protocols such as multiple dosing through controlled release formulations that provide the desired therapeutic effect with dosing of once-a-day or less.
The report provides developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, opportunities for injection devices that are designed for patient self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Evolution in Therapeutic Care
Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.
Numerous graphs, charts, tables and visualizations complement the analysis
Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.
What You Will Learn
- Analyzes and evaluates modified release neurology therapeutics products and assesses the market potential for existing and probable future products
- Analyzes product strategies, technologies and market development issues
- Provides detailed analysis of neurology market segments, market demographics, and therapeutic strategies
- Profiles market sector companies, their product development activities, business strategies, and corporate alliances and affiliations
- Evaluates the impact of economic, technology, and regulatory factors on neurology drug markets
Table of Contents – Modified Release Neurology Therapeutics
The Market Opportunity
The Neurological Drug Market Dynamics
The Trend Toward Self-Administration
Route of Administration
Innovation in Drug Formulation
Neurological Drugs and As-supplied Packaging
Delivering Neurological Drugs via Injection
Innovation in Injectable Device Designs
Drug Delivery Device Selection Issues
Therapeutic Demand Drivers
Key Market Factors
MR Neurological Product Analysis
Proprietary Formulation Technology
ChroniJect (Oakwood Laboratories/PharmaSophia)
CriticalMix (Critical Pharmaceuticals)
Q-Sphera (Midatech Pharma)
Physical Process Control Methods
SCF for Nanoparticle Formulations
Formulplex (Supercritical Solutions)
SCF extraction of emulsions (SFEE)
Therapeutic Market Sectors
Market Sector Analysis and Forecasts
Key Market Factors
Forecasts and Market Data
This Report is also available from Global Information, Inc.